Impact of neoadjuvant pembrolizumab adherence on pathologic complete response in triple-negative breast cancer: a real-world analysis.

Alexis LeVeeMegan WongSarah FloresNora RuelHeather McArthurJames WaismanJoanne Mortimer

Published in: The oncologist (2024)

In this real-world analysis of patients with TNBC treated with NAC plus pembro, younger age and the completion of at least 8 cycles of pembrolizumab were associated with pCR.

Keyphrases

locally advanced
advanced non small cell lung cancer
rectal cancer
neoadjuvant chemotherapy
transcription factor
lymph node
type diabetes
glycemic control
real time pcr